Poly(ADP-ribose) polymerase 1 deficiency increases nitric oxide production and attenuates aortic atherogenesis through downregulation of arginase II
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Poly(ADP-ribose) polymerase 1 deficiency increases nitric oxide production and attenuates aortic atherogenesis through downregulation of arginase II
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
Volume 44, Issue 1, Pages 114-122
Publisher
Wiley
Online
2016-10-19
DOI
10.1111/1440-1681.12685
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Poly(ADP-Ribose) Polymerase 1 Inhibition Improves Coronary Arteriole Function in Type 2 Diabetes Mellitus
- (2012) Soo-Kyoung Choi et al. HYPERTENSION
- Arginase-2 Mediates Diabetic Renal Injury
- (2011) Sidney M. Morris et al. DIABETES
- Poly (ADP-Ribose) Polymerase Inhibition Attenuates Atherosclerotic Plaque Development in ApoE-/- Mice with Hyperhomocysteinemia
- (2011) Jiang-jiao Xie et al. Journal of Atherosclerosis and Thrombosis
- The Clinically Active PARP Inhibitor AG014699 Ameliorates Cardiotoxicity but Does Not Enhance the Efficacy of Doxorubicin, despite Improving Tumor Perfusion and Radiation Response in Mice
- (2011) M. Ali et al. MOLECULAR CANCER THERAPEUTICS
- Mitochondrial and Nuclear Cross Talk in Cell Death
- (2010) Shaida A. Andrabi et al. Annals of the New York Academy of Sciences
- Piceatannol-3'-O-β-D-glucopyranoside as an active component of rhubarb activates endothelial nitric oxide synthase through inhibition of arginase activity
- (2010) Ainieng Woo et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
- (2010) M William Audeh et al. LANCET
- Arginase Activities and Global Arginine Bioavailability in Wild-Type and ApoE-Deficient Mice: Responses to High Fat and High Cholesterol Diets
- (2010) Aaron Erdely et al. PLoS One
- Inactivation of the Adenosine A 2A Receptor Protects Apolipoprotein E–Deficient Mice From Atherosclerosis
- (2009) Huan Wang et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Arginase Promotes Neointima Formation in Rat Injured Carotid Arteries
- (2009) Kelly J. Peyton et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- A Phase IB Trial of Intravenous INO-1001 Plus Oral Temozolomide in Subjects with Unresectable Stage-III or IV Melanoma
- (2009) Agop Y. Bedikian et al. CANCER INVESTIGATION
- Atherosclerotic plaque development
- (2009) Quang T. Bui et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Thieno[2,3-c]Isoquinolin-5-one, a Potent Poly(ADP-Ribose) Polymerase Inhibitor, Promotes Atherosclerotic Plaque Regression in High-Fat Diet-Fed Apolipoprotein E-Deficient Mice: Effects on Inflammatory Markers and Lipid Content
- (2009) C. P. Hans et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Protective Effects of PARP-1 Knockout on Dyslipidemia-Induced Autonomic and Vascular Dysfunction in ApoE−/− Mice: Effects on eNOS and Oxidative Stress
- (2009) Chetan P. Hans et al. PLoS One
- eNOS, metabolic syndrome and cardiovascular disease
- (2009) Paul L. Huang TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Role of the Peroxynitrite-Poly(ADP-Ribose) Polymerase Pathway in Human Disease
- (2008) Pal Pacher et al. AMERICAN JOURNAL OF PATHOLOGY
- Endothelial Arginase II
- (2008) Sungwoo Ryoo et al. CIRCULATION RESEARCH
- Reciprocal regulation of iNOS and PARP-1 during allergen-induced eosinophilia
- (2008) A. S. Naura et al. EUROPEAN RESPIRATORY JOURNAL
- Arginase I Induction by Modified Lipoproteins in Macrophages: A Peroxisome Proliferator-Activated Receptor-γ/δ-Mediated Effect that Links Lipid Metabolism and Immunity
- (2008) Alejandro Gallardo-Soler et al. MOLECULAR ENDOCRINOLOGY
- Imidazoquinolinone, Imidazopyridine, and Isoquinolindione Derivatives as Novel and Potent Inhibitors of the Poly(ADP-ribose) Polymerase (PARP): A Comparison with Standard PARP Inhibitors
- (2008) T. Eltze et al. MOLECULAR PHARMACOLOGY
- Arginase and pulmonary diseases
- (2008) Harm Maarsingh et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search